Cargando…
Subacute Massive Pulmonary Embolism Treated With Streptokinase
Subacute massive pulmonary embolism occurs insidiously over weeks, has a high mortality rate, and may be less amenable to systemic thrombolysis. It is associated with a high likelihood of the development of pulmonary hypertension. The subacute presentation makes it difficult to diagnose leading to t...
Autores principales: | Solanki, Naisargee N, Tanwar, Narendra, Solanki, Nilesh D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686918/ https://www.ncbi.nlm.nih.gov/pubmed/33251065 http://dx.doi.org/10.7759/cureus.11157 |
Ejemplares similares
-
Outcomes of Catheter-Based Pulmonary Artery Embolectomy in Patients With Sub-Massive to Massive Pulmonary Embolism
por: Elmoghrabi, Adel, et al.
Publicado: (2023) -
Subacute Cardiac Tamponade With Massive Pericardial Effusion
por: Hein, Aung, et al.
Publicado: (2022) -
A Complicated Case of COVID-19-Induced Inferolateral Wall Myocardial Infarction Successfully Treated With Streptokinase
por: Hussain, Taimoor, et al.
Publicado: (2021) -
Successful Intraosseous Thrombolysis in the Management of a Massive Pulmonary Embolism With Cardiac Arrest
por: Nweze, Kirsty, et al.
Publicado: (2020) -
Right Ventricle Thrombus in a Massive Pulmonary Embolism COVID-19 Patient
por: Gaspar, Vasco, et al.
Publicado: (2023)